NR 576 Week 4 Clinical Reasoning Write-Up Example

Clinical Reasoning Write-Up: Separating Progressing Diabetic Neuropathy From Vitamin B12 Deficiency When Both Explain Numbness, and What an Unremarkable Result Would Mean

Student Name

College of Nursing, Chamberlain University

NR 576: Differential Diagnosis in Adult-Gerontology Primary Care

Instructor Name

Month Day, Year

Clinical Reasoning Write-Up: Separating Progressing Diabetic Neuropathy From Vitamin B12 Deficiency When Both Explain Numbness, and What an Unremarkable Result Would Mean

The Two Survivors

After the episodic visit, two explanations remain for the progression of this 78-year-old's numbness and imbalance: the established diabetic neuropathy, further along than the chart suggested, and vitamin B12 deficiency, a new condition probably related to 15 years of metformin and nine years of omeprazole. A third explanation, orthostatic hypotension from tamsulosin, accounts for the falls on standing but not for the numbness, and it is handled separately.

What They Share

Both explain numbness in the feet and legs, reduced vibration sense, absent ankle reflexes, an unsteady gait and falls. Both can produce symptoms in the hands. Both are more common in older adults with diabetes, and both can coexist in the same person. Nothing in the patient's symptoms alone separates them, and most of the case is equally well explained by either.

What Each Would Make Observable

If the diabetic neuropathy alone were responsible, the following should be true. The loss should be length-dependent: touch, vibration and position sense should fall off together from the toes upward, with the hands affected only after the legs are involved to about the knee. The reflexes should be reduced or absent throughout, not brisk at the knee. The course should be slow, over years. The blood count should be unaffected by the neuropathy itself. And the patient's glucose control, an A1c of 6.8% and stable, would make rapid progression unexpected.

If B12 deficiency were responsible, different things should be observable. Position and vibration sense should be lost out of proportion to touch, because the posterior columns of the spinal cord carry them. The Romberg test should be positive. Reflexes may be mixed: brisk at the knee from spinal cord involvement while absent at the ankle from peripheral nerve involvement. The course should be over months. The blood may show a macrocytic anemia, and memory may be affected. And the metabolic markers should be abnormal: a low or borderline B12 with a raised methylmalonic acid (Stabler, 2013).

The predictions are not the same kind of thing. The neuropathy explanation predicts a course and a pattern; the deficiency explanation predicts findings someone can go and measure. That asymmetry decides the order of the next steps.

What the Examination Already Shows

Three observations already favor the deficiency: position sense lost at the great toes while touch is reduced only to mid-shin, a positive Romberg, and brisk knee reflexes beside absent ankle reflexes. A mean corpuscular volume of 102 adds weight. The timing, fingertip involvement within six months, also fits the deficiency better than slow neuropathy. None of these proves it.

The Separating Steps and What Each Result Would Mean

Serum B12. A clearly low result, under about 200 pg/mL, supports the deficiency. An unremarkable result, above about 400, makes it much less likely. A borderline result, between those values, is the most likely outcome in older adults and settles nothing on its own, which is why the next step exists.

Methylmalonic acid. Raised methylmalonic acid with a borderline B12 supports deficiency at the tissue level. A normal methylmalonic acid with a borderline B12 argues against it. Kidney disease can raise methylmalonic acid, so the patient's creatinine must be read alongside it.

Response to replacement. If the deficiency is confirmed, position sense and the Romberg should improve over weeks to months of replacement, while the long-standing diabetic loss would not. An absence of any improvement after three months would weaken the deficiency as an explanation for the neurologic findings, though nerve damage that has been present for a long time may recover only partly.

A Third Possibility Considered and Set Aside for Now

Cervical spondylotic myelopathy can also produce posterior column loss with brisk reflexes below the level of compression, and it is common at this age. What would make it observable: neck pain or stiffness, clumsy hands, a Hoffmann sign, brisk reflexes in the arms and a level on examination. The patient has no neck pain, normal hand dexterity, normal arm reflexes and no Hoffmann sign. That does not exclude it, but it lowers its place on the list for now, pending the blood results. If the B12 and methylmalonic acid come back normal, or if the posterior column signs do not improve with replacement, cervical imaging becomes the next step, and the order of the work-up changes accordingly.

How Glucose Control Bears on the Question

The patient's A1c has been between 6.6% and 7.1% for five years. Diabetic neuropathy can progress even with good control, but rapid progression over months in a patient whose control has been steady is less expected than slow progression over years. The steady control therefore weighs slightly against the established neuropathy as the explanation for the recent change, without excluding it.

The Drug Possibility, Kept Open

Metformin and omeprazole are not only background; they are the proposed cause of the deficiency. The risk rises with years of use (Aroda et al., 2016). In a randomized trial, metformin lowered B12 levels compared with placebo over about four years, and the absolute risk of deficiency was 7.2 percentage points higher with metformin (de Jager et al., 2010). The drug branch is not settled by a laboratory result alone: even if the B12 comes back borderline, the question of whether to continue omeprazole is a separate decision.

Why the Order of the Steps Matters

The blood tests come first because they are quick, cheap and directly test the deficiency. Nerve conduction studies would not separate the two explanations well, since both can reduce sensory responses in the legs, and they would not test the spinal cord. Spinal imaging comes only if the blood tests do not explain the posterior column signs. Starting with the test that can confirm one explanation outright saves the patient tests that would only describe the neuropathy again.

Where the Write-Up Lands

On present evidence I lead with both explanations operating together: a long-standing diabetic neuropathy accounting for the stocking touch loss and absent ankle reflexes, and a probable B12 deficiency accounting for the posterior column signs, the speed of change and the macrocytosis. The separating steps will test the second explanation directly, and the response to replacement will test whether it accounts for the imbalance.

References

Aroda, V. R., Edelstein, S. L., Goldberg, R. B., Knowler, W. C., Marcovina, S. M., Orchard, T. J., Bray, G. A., Schade, D. S., Temprosa, M. G., White, N. H., & Crandall, J. P. (2016). Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. Journal of Clinical Endocrinology & Metabolism, 101(4), 1754-1761. https://doi.org/10.1210/jc.2015-3754

de Jager, J., Kooy, A., Lehert, P., Wulffele, M. G., van der Kolk, J., Bets, D., Verburg, J., Donker, A. J. M., & Stehouwer, C. D. A. (2010). Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: Randomised placebo controlled trial. BMJ, 340, Article c2181. https://doi.org/10.1136/bmj.c2181

Stabler, S. P. (2013). Vitamin B12 deficiency. New England Journal of Medicine, 368(2), 149-160. https://doi.org/10.1056/NEJMcp1113996